MAPT and Alzheimer disease: In conclusion, this large‐scale study confirmed that retinal structure was significantly altered in patients with AD and that OCT measurements correlated with cognitive function, MRI findings indicative of cerebral atrophy, tau and Aβ levels in the CSF, and APOE genotypes.